Skip to main content

COVID-19 CPT testing codes

Horizon BCBSNJ is prepared to accept the following codes based on Horizon BCBSNJ’s policies and procedures:

Code Description
U0001 CDC testing laboratories to test patients for SARS-CoV-2
U0002 Non-CDC laboratory tests for SARS-CoV-2/2019-nCoV (COVID-19)
U0003 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique, making use of high throughput technologies as described by CMS-2020-01-R.
U0004 2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple
types or subtypes (includes all targets), non-CDC, making use of high throughput technologies as described by CMS-2020-01-R.
86328 Immunoassay for infectious agent antibody(ies), qualitative or semi-qualitative, single step method (e.g., reagent strip): severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); Represents a simple single-step test, often used as a point-of-care test, that could be done in a physician office setting (Coverage in adults requires evidence for an individualized clinical assessment based on CDC recommendations.)
86769 Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); Represents a multi-step method test, likely to be done by an independent lab or hospital (Coverage in adults requires evidence for an individualized clinical assessment based on CDC recommendations.)
87635 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique
99000 Handling and/or conveyance of specimen for transfer from the office to a laboratory
99001 Handling and/or conveyance of specimen for transfer from the patient in other than an office to a laboratory (distance may be indicated)
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), any specimen source (Billable by clinical diagnostic laboratories.)
G2024 Specimen collection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), from an individual in a skilled nursing facility or by a laboratory on behalf of a home health agency, any specimen source (Billable by clinical diagnostic laboratories.)

Please visit the NCCI for additional guidance.